Retraction. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

J Clin Invest. 2015 May;125(5):2179. doi: 10.1172/JCI81878. Epub 2015 May 1.

Authors

Stephanie K. Watkins, Ziqiang Zhu, Elena Riboldi, Kim A. Shafer-Weaver, Katherine E.R. Stagliano, Martha M. Sklavos, Stefan Ambs, Hideo Yagita, Arthur A. Hurwitz

No abstract available

Publication types

Retraction of Publication